Gregory Ho

Fiering lab

Greg received a Bachelor of Arts degree in Biology from Colby College. Before joining MCB, Greg was a research technician in Duprex Lab at the National Emerging Infectious Disease Laboratories in Boston, studying novel Morbilliviruses. Greg is pursuing his Ph.D in Immunology in the Fiering lab, investigating in situ plasmid electroporation as a solid tumor cancer therapeutic. Outside of lab, Greg takes full advantage of being in the Upper Valley. You will find him organizing and playing soccer with the Dartmouth Graduate Soccer club, running on the Northern Rail Trail or hiking in the various mountain ranges in Vermont or New Hampshire.


HB Hinman Box 7937

Selected Publications

  • Stump CT, Ho G, Mao C, Veliz FA, Beiss V, Fields J, Steinmetz NF, Fiering S. Remission-Stage Ovarian Cancer Cell Vaccine with Cowpea Mosaic Virus Adjuvant Prevents Tumor Growth. Cancers (Basel). 2021 Feb 5;13(4):627. doi: 10.3390/cancers13040627. PMID: 33562450; PMCID: PMC7915664.

    Tilston-Lunel NL, Welch SR, Nambulli S, de Vries RD, Ho GW, Wentworth DE, Shabman R, Nichol ST, Spiropoulou CF, de Swart RL, Rennick LJ, Duprex WP. Sustained Replication of Synthetic Canine Distemper Virus Defective Genomes In Vitro and In Vivo. mSphere. 2021 Oct 27;6(5):e0053721. doi: 10.1128/mSphere.00537-21. Epub 2021 Sep 22. PMID: 34550005; PMCID: PMC8550193.